(Q72757765)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6211978%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6211978%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

main subject

parathyroid carcinoma

1 reference

E. Shane

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6211978

30 August 2023

T. P. Jacobs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6211978

30 August 2023

E. S. Siris

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6211978

30 August 2023

S. F. Steinberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6211978

30 August 2023

K. Stoddart

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6211978

30 August 2023

R. E. Canfield

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6211978

30 August 2023

J. P. Bilezikian

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6211978

30 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6211978

30 August 2023

publication date

1 June 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6211978%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 October 2019

https://api.elsevier.com/content/article/PII:0002934382908555?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

https://api.elsevier.com/content/article/PII:0002934382908555?httpAccept=text/plain

30 August 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

American Journal of Medicine

30 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6211978%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6211978%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6211978%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

939-944

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6211978%20AND%20SRC:MED&resulttype=core&format=json

Parathyroid carcinoma.A study of 70 cases

29 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Parathyroid carcinoma: a collective review

30 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Surgical resection of metastatic parathyroid carcinoma

30 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Hyperfunctioning carcinoma of the parathyroid gland

30 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma

30 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Long-term administration of calcitonin for hypercalcemia secondary to recurrent parathyroid carcinoma

30 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Mithramycin Treatment of Intractable Hypercalcemia Due to Parathyroid Carcinoma

30 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

30 August 2023

Diphosphonates

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma

30 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases

30 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease

30 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate

30 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism

30 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Modifications of a specific assay for hydroxyproline in urine

30 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone

30 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects

30 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(82)90855-5

30 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6211978%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference